Serpoĉela anemio (Esperanto Wikipedia)

Analysis of information sources in references of the Wikipedia article "Serpoĉela anemio" in Esperanto language version.

refsWebsite

Global rank Esperanto rank

21doi.org

2^nd place

7^th place

5nejm.org

2,374^th place

3,693^rd place

3web.archive.org

1^st place

3fda.gov

447^th place

1,065^th place

2wiley.com

222^nd place

188^th place

2nih.gov

4^th place

9^th place

2jamanetwork.com

2,650^th place

2,597^th place

1eatright.org

low place

1noir-et-blanc.org

low place

1jci.org

low place

1researchgate.net

120^th place

148^th place

1bloodjournal.org

low place

1ashpublications.org

low place

1apipd.fr

low place

1medicalnewstoday.com

3,011^th place

low place

apipd.fr

La drépanocytose : traitements et bonnes pratiques (france). Association Pour l'Information et la Prévention de la Drépanocytose (APIDP) (2015)..

ashpublications.org

Henry ER, Metaferia B, Li Q et al. Treatment of sickle cell disease by increasing oxygen affinity of hemoglobin, Blood, 2021;138:1172-1181

bloodjournal.org

Yutaka Niihara, Han A. Koh, Lan Tran, Rafael Razon, Henry Macan, Charles Stark, Ted Wun kaj Patricia Adams-Graves (décembre 2014). “A Phase 3 Study of L-Glutamine Therapy for Sickle Cell Anemia and Sickle ß0-Thalassemia”, Blood (en) 124 (21), p. 86. Alirita 28-a de decembro 2017.. .

doi.org

E. G. Davies, C. Riddington, R. Lottenberg kaj N. Dower (januaro 2004). “Pneumococcal vaccines for sickle cell disease”, The Cochrane Database of Systematic Reviews (en) 1. doi:10.1002/14651858.CD003885.pub2. CD003885. Alirita 26-a de decembro 2017.. .
(februaro 2018) “Does physical activity increase or decrease the risk of sickle cell disease complications?”, British Journal of Sports Medicine 52 (4), p. 214–218. doi:10.1136/bjsports-2015-095317. 24464344.
Frédéric B. Piel, Martin H. Steinberg kaj David C. Rees (avril 2017). “Sickle Cell Disease”, The New England Journal of Medicine (en) 376 (16), p. 1561–1573. doi:10.1056/NEJMra1510865. Alirita 27 decembro 2017.. .
L. M. Rabb, Yvonne Grandison, Karlene Mason, R. J. Hayes, Beryl Serjeant kaj G. R. Serjeant (aŭgusto 1983). “A trial of folate supplementation in children with homozygous sickle cell disease”, British Journal of Haematology (en) 54 (4), p. 589–594. doi:10.1111/j.1365-2141.1983.tb02138.x. Alirita 28-a de decembro 2017.. .
(novembro 2019) “Malaria chemoprophylaxis in sickle cell disease”, The Cochrane Database of Systematic Reviews 2019 (11). doi:10.1002/14651858.CD003489.pub2.
(septembro 2022) “Hydroxyurea (hydroxycarbamide) for sickle cell disease”, The Cochrane Database of Systematic Reviews 2022 (10), p. CD002202. doi:10.1002/14651858.CD002202.pub3.
Samuel Charache, Michael L. Terrin, Richard D. Moore, George J. Dover, Franca B. Barton, Susan V. Eckert, Robert P. McMahon, Ph.D., Duane R. Bonds kaj esplorantoj de la Multicenter Study of Hydroxyurea in Sickle Cell Anemia (mai 1995). “Effect of Hydroxyurea on the Frequency of Painful Crises in Sickle Cell Anemia”, The New England Journal of Medicine (en) 332 (20), p. 1317–1322. doi:10.1056/NEJM199505183322001. Alirita 28-a de decembro 2017.. .
Martin H. Steinberg, Franca Barton, Oswaldo Castro, Charles H. Pegelow, Samir K. Ballas, Abdullah Kutlar, Eugene Orringer, Rita Bellevue, Nancy Olivieri, James Eckman, Mala Varma, Gloria Ramirez, Brian Adler, Wally Smith, Timothy Carlos, Kenneth Ataga, Laura DeCastro, Carolyn Bigelow, Yogen Saunthararajah, Margaret Telfer, Elliott Vichinsky, Susan Claster, Susan Shurin, Kenneth Bridges, Myron Waclawiw, Duane Bonds kaj Michael Terrin (avril 2003). “Effect of Hydroxyurea on Mortality and Morbidity in Adult Sickle Cell Anemia. Risks and Benefits Up to 9 Years of Treatment”, JAMA (en) 289 (13), p. 1645–1651. doi:10.1001/jama.289.13.1645. Alirita 27-a de decembro 2017.. .
O. S. Platt, S. H. Orkin, G. Dover, G. P. Beardsley, B. Miller kaj D. G. Nathan (aŭgusto 1984). “Hydroxyurea enhances fetal hemoglobin production in sickle cell anemia”, The Journal of Clinical Investigation (en) 74 (2), p. 652–656. doi:10.1172/JCI111464. Alirita 27-a de decembro 2017.. .
Barbara P. Yawn, George R. Buchanan, Araba N. Afenyi-Annan, Samir K. Ballas, Kathryn L. Hassell, Andra H. James, Lanetta Jordan, Sophie M. Lanzkron, Richard Lottenberg, William J. Savage, Paula J. Tanabe, Russell E. Ware, M. Hassan Murad, Jonathan C. Goldsmith, Eduardo Ortiz, Robinson Fulwood, Ann Horton kaj Joylene John-Sowah (septembro 2014). “Management of Sickle Cell Disease. Summary of the 2014 Evidence-Based Report by Expert Panel Members”, JAMA (en) 312 (10), p. 1033–1048. doi:10.1001/jama.2014.10517. Alirita 25-a de decembro 2017.. .
Orah S. Platt (mars 2008). “Hydroxyurea for the Treatment of Sickle Cell Anemia”, The New England Journal of Medicine (en) 358 (13), p. 1362–1369. doi:10.1056/NEJMct0708272. Alirita 28-a de decembro 2017.. .
(marto 2011) “Blood transfusion usage among adults with sickle cell disease – a single institution experience over ten years”, British Journal of Haematology 152 (6), p. 766–770. doi:10.1111/j.1365-2141.2010.08451.x. 44562296.
(July 1998) “Prevention of a first stroke by transfusions in children with sickle cell anemia and abnormal results on transcranial Doppler ultrasonography”, The New England Journal of Medicine 339 (1), p. 5–11. doi:10.1056/NEJM199807023390102.
(January 2011) “Effect of chronic red cell transfusion therapy on vasculopathies and silent infarcts in patients with sickle cell disease”, American Journal of Hematology 86 (1), p. 104–106. doi:10.1002/ajh.21901.
(March 2010) “Feasibility and efficacy of chronic transfusion for stroke prevention in children with sickle cell disease”, European Journal of Haematology 84 (3), p. 259–265. doi:10.1111/j.1600-0609.2009.01379.x. 24316310.
(majo 2015) “Psychological therapies for sickle cell disease and pain”, The Cochrane Database of Systematic Reviews 2015 (5), p. CD001916. doi:10.1002/14651858.CD001916.pub3.
(January 2020) “Opioid treatment for acute and chronic pain in patients with sickle cell disease”, Neuroscience Letters 714, p. 134534. doi:10.1016/j.neulet.2019.134534. 203667575.
(julio 2017) “Fluid replacement therapy for acute episodes of pain in people with sickle cell disease”, The Cochrane Database of Systematic Reviews 7 (4), p. CD005406. doi:10.1002/14651858.CD005406.pub5.
(septembro 2019) “Antibiotics for treating acute chest syndrome in people with sickle cell disease”, The Cochrane Database of Systematic Reviews 9 (4), p. CD006110. doi:10.1002/14651858.CD006110.pub5.
(januaro 2020) “Blood transfusions for treating acute chest syndrome in people with sickle cell disease”, The Cochrane Database of Systematic Reviews 1 (1), p. CD007843. doi:10.1002/14651858.CD007843.pub4.
(decembro 2019) “Treatment for avascular necrosis of bone in people with sickle cell disease”, The Cochrane Database of Systematic Reviews 2019 (12), p. CD004344. doi:10.1002/14651858.CD004344.pub7.

eatright.org

Nutrition for the Child with Sickle Cell Anemia (angle). Arkivita el la originalo je 19-a de junio 2020. Alirita 5-a de oktobro 2019 .

fda.gov

Office of the Commissioner (7-a de julio 2017) Press Announcements – FDA approves new treatment for sickle cell disease (angle). Arkivita el la originalo je 10-a de julio 2017. Alirita 10-a de julio 2017 .
FDA approves new treatment for sickle cell disease (angle). www.fda.gov (julio 2017). Alirita 28-a de decembro 2017 ..
Center for Drug Evaluation and Research (20-a de decembro 2019). “FDA approves crizanlizumab-tmca for sickle cell disease”, FDA (en).

jamanetwork.com

Martin H. Steinberg, Franca Barton, Oswaldo Castro, Charles H. Pegelow, Samir K. Ballas, Abdullah Kutlar, Eugene Orringer, Rita Bellevue, Nancy Olivieri, James Eckman, Mala Varma, Gloria Ramirez, Brian Adler, Wally Smith, Timothy Carlos, Kenneth Ataga, Laura DeCastro, Carolyn Bigelow, Yogen Saunthararajah, Margaret Telfer, Elliott Vichinsky, Susan Claster, Susan Shurin, Kenneth Bridges, Myron Waclawiw, Duane Bonds kaj Michael Terrin (avril 2003). “Effect of Hydroxyurea on Mortality and Morbidity in Adult Sickle Cell Anemia. Risks and Benefits Up to 9 Years of Treatment”, JAMA (en) 289 (13), p. 1645–1651. doi:10.1001/jama.289.13.1645. Alirita 27-a de decembro 2017.. .
Barbara P. Yawn, George R. Buchanan, Araba N. Afenyi-Annan, Samir K. Ballas, Kathryn L. Hassell, Andra H. James, Lanetta Jordan, Sophie M. Lanzkron, Richard Lottenberg, William J. Savage, Paula J. Tanabe, Russell E. Ware, M. Hassan Murad, Jonathan C. Goldsmith, Eduardo Ortiz, Robinson Fulwood, Ann Horton kaj Joylene John-Sowah (septembro 2014). “Management of Sickle Cell Disease. Summary of the 2014 Evidence-Based Report by Expert Panel Members”, JAMA (en) 312 (10), p. 1033–1048. doi:10.1001/jama.2014.10517. Alirita 25-a de decembro 2017.. .

jci.org

O. S. Platt, S. H. Orkin, G. Dover, G. P. Beardsley, B. Miller kaj D. G. Nathan (aŭgusto 1984). “Hydroxyurea enhances fetal hemoglobin production in sickle cell anemia”, The Journal of Clinical Investigation (en) 74 (2), p. 652–656. doi:10.1172/JCI111464. Alirita 27-a de decembro 2017.. .

medicalnewstoday.com

Higher Doses Of Morphine Justified For Sickle Cell Patients (angle). [1] (majo 2011). Alirita 27-a de decembro 2017 ..

nejm.org

Frédéric B. Piel, Martin H. Steinberg kaj David C. Rees (avril 2017). “Sickle Cell Disease”, The New England Journal of Medicine (en) 376 (16), p. 1561–1573. doi:10.1056/NEJMra1510865. Alirita 27 decembro 2017.. .
Samuel Charache, Michael L. Terrin, Richard D. Moore, George J. Dover, Franca B. Barton, Susan V. Eckert, Robert P. McMahon, Ph.D., Duane R. Bonds kaj esplorantoj de la Multicenter Study of Hydroxyurea in Sickle Cell Anemia (mai 1995). “Effect of Hydroxyurea on the Frequency of Painful Crises in Sickle Cell Anemia”, The New England Journal of Medicine (en) 332 (20), p. 1317–1322. doi:10.1056/NEJM199505183322001. Alirita 28-a de decembro 2017.. .
Orah S. Platt (mars 2008). “Hydroxyurea for the Treatment of Sickle Cell Anemia”, The New England Journal of Medicine (en) 358 (13), p. 1362–1369. doi:10.1056/NEJMct0708272. Alirita 28-a de decembro 2017.. .
Vichinsky E, Hoppe CC, Ataga KI et al. A phase 3 randomized trial of voxelotor in sickle cell disease, N Engl J Med, 2019;381:509-519
Bunn HF, Oxygen delivery in the treatment of anemia, N Eng J Med, 2022;387:2362-2365

nih.gov

nhlbi.nih.gov

Evidence-Based Management of Sickle Cell Disease (2014). Alirita 16-a de novembro 2017 .
How Is Sickle Cell Disease Treated? (12-a de junio 2015). Arkivita el la originalo je 9-a de marto 2016. Alirita 8-a de marto 2016 .

noir-et-blanc.org

Noir&Blanc Escroquerie : le VK500

researchgate.net

Richard D. Moore, Samuel Charache, Michael L. Terrin, Franca B. Barton, Samir K. Ballas, E. Orringer, S. Jones, D. Strayhorn, W. Rosse, G. Phillips, D. Peace, A. Johnson-Telfair, P. Milner, A. Kutlar, A. Tracy, S. K. Ballas, G. E. Allen, J. Moshang, B. Scott, M. Steinberg kaj al. (mai 2000). “Cost-Effectiveness of Hydroxyurea in Sickle Cell Anemia”, American Journal of Hematology (en) 64 (1), p. 26–31. doi:[[doi:10.1002%2F%28SICI%291096-8652%28200005%2964%3A1%3C26%3A%3AAID-AJH5%3E3.0.CO%3B2-F|10.1002/(SICI)1096-8652(200005)64:1<26::AID-AJH5>3.0.CO;2-F]]. Alirita 27-a de decembro 2017.. .

web.archive.org

Nutrition for the Child with Sickle Cell Anemia (angle). Arkivita el la originalo je 19-a de junio 2020. Alirita 5-a de oktobro 2019 .
Office of the Commissioner (7-a de julio 2017) Press Announcements – FDA approves new treatment for sickle cell disease (angle). Arkivita el la originalo je 10-a de julio 2017. Alirita 10-a de julio 2017 .
How Is Sickle Cell Disease Treated? (12-a de junio 2015). Arkivita el la originalo je 9-a de marto 2016. Alirita 8-a de marto 2016 .

wiley.com

onlinelibrary.wiley.com

E. G. Davies, C. Riddington, R. Lottenberg kaj N. Dower (januaro 2004). “Pneumococcal vaccines for sickle cell disease”, The Cochrane Database of Systematic Reviews (en) 1. doi:10.1002/14651858.CD003885.pub2. CD003885. Alirita 26-a de decembro 2017.. .
L. M. Rabb, Yvonne Grandison, Karlene Mason, R. J. Hayes, Beryl Serjeant kaj G. R. Serjeant (aŭgusto 1983). “A trial of folate supplementation in children with homozygous sickle cell disease”, British Journal of Haematology (en) 54 (4), p. 589–594. doi:10.1111/j.1365-2141.1983.tb02138.x. Alirita 28-a de decembro 2017.. .